Treatment of diabetic mice with the SGLT2 inhibitor TA-1887 antagonizes diabetic cachexia and decreases mortality

Metabolic syndrome: SGLT2i prevents diabetic cachexia and prolongs survival Sodium-glucose cotransporter 2 inhibitor (SGLT2i) has a favorable effect on mortality of diabetic subjects, but the mechanism stays unclear. Taichi Sugizaki at Kumamoto University examined SGLT2i effects in severe diabetic o...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Taichi Sugizaki, Shunshun Zhu, Ge Guo, Akiko Matsumoto, Jiabin Zhao, Motoyoshi Endo, Haruki Horiguchi, Jun Morinaga, Zhe Tian, Tsuyoshi Kadomatsu, Keishi Miyata, Hiroshi Itoh, Yuichi Oike
Format: article
Langue:EN
Publié: Nature Portfolio 2017
Sujets:
Accès en ligne:https://doaj.org/article/a2c42276f5e74aac86a47284b4a91626
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!